The patient journey has changed dramatically over the past decade. What was once a relatively simple path, visit the doctor, receive a diagnosis, pick up a prescription, and start treatment, has evolved into a much more complex experience for patients.
Today, patients must navigate a series of steps that often include genetic testing, specialist referrals, insurance approvals, specialty pharmacies, and financial verification. At the same time, they are exposed to an overwhelming amount of information online from social media, AI tools, patient forums, and digital health platforms.
For pharmaceutical leaders, patient services teams, and patient engagement professionals, this shift has created a new challenge: helping patients navigate a healthcare system that has become more advanced, but also far more confusing.
In the latest episode of The Patient Experience Podcast, hosts Bob Miglani, former Pfizer leader and CEO of Hoot, and Jason Grossman, a biotech executive with more than 25 years of commercial and patient services leadership experience, explore what they call a growing patient confusion crisis and why understanding the evolution of the patient journey is critical for the future of pharma.
Watch the Episode
You can watch the full conversation here:
The Patient Journey Is No Longer Simple
For many years, the traditional patient journey followed a fairly predictable path. A patient would visit their doctor, receive a diagnosis, obtain a prescription, and begin treatment. While the healthcare system has never been perfect, the process itself was relatively straightforward.
Today, that journey looks very different.
Advances in personalized medicine, oncology, rare disease treatments, and gene therapies have dramatically expanded the possibilities for treating patients. But these breakthroughs also introduce new layers of complexity.
A patient may now leave the doctor’s office with a series of next steps that include diagnostic testing, consultations with specialists, insurance verification, and coordination with specialty pharmacies. These steps can take weeks or even months to complete.
While innovation has improved clinical outcomes, the path to treatment has become far more complicated for patients to navigate.
The Rise of the Patient Confusion Crisis
One of the most important themes discussed in the podcast episode is what Bob and Jason describe as a patient confusion crisis.
Patients today have access to more information than ever before. They can search symptoms online, join patient communities on social media, ask questions through AI tools, and read countless personal experiences shared across the internet.
While access to information can be empowering, it can also create confusion.
Patients frequently leave medical appointments with unanswered questions and then turn to the internet for clarification. They may encounter conflicting opinions, anecdotal stories, or misinformation that causes them to question their treatment plan.
This uncertainty often leads to delays in starting therapy or discontinuing treatment early. In some cases, patients simply become overwhelmed and hesitate to move forward.
For pharmaceutical companies investing billions in research and development, this gap between diagnosis and treatment represents a significant challenge.
Why Physicians No Longer Have Time to Educate Patients
Another major factor shaping the modern patient journey is time.
Physicians today are under immense pressure to see more patients while managing increasingly complex diseases. Appointments that once allowed time for detailed conversations are now often limited to just a few minutes.
As a result, patients frequently leave appointments without fully understanding their condition, treatment options, or what to expect next.
Doctors remain the most trusted source of medical information, but the healthcare system no longer gives them enough time to guide patients through the entire journey.
This is where the gap begins to emerge between medical innovation and patient understanding.
Direct-to-Patient Healthcare Is Changing the Landscape
The healthcare industry is also experiencing a shift toward Direct-to-Patient models.
Patients are increasingly accessing healthcare services through digital platforms, telemedicine providers, online pharmacies, and direct purchasing options. Companies like GoodRx and emerging digital health providers are reshaping how patients access treatments and manage their care.
At the same time, pharmaceutical companies are beginning to rethink how they engage patients directly, rather than relying solely on traditional physician channels.
While this shift can improve access and transparency, it also increases the need for clear, trusted patient education. If patients are making more decisions outside the clinic, they need reliable guidance that helps them understand their treatment and stay on therapy.
Why Patient Education Must Extend Beyond the Clinic
One of the most important insights from the episode is that healthcare decisions increasingly happen outside the doctor’s office.
Many patients leave their appointments and discuss treatment options with family members at home. They research information online, watch videos, or consult friends who have experienced similar conditions.
In other words, critical healthcare decisions are often made at the kitchen table, not in the clinic.
For pharmaceutical companies, this represents a major opportunity. By helping physicians extend trusted education beyond the appointment through digital tools, video, and patient-friendly content, organizations can help patients better understand their treatment journey.
When patients feel informed and confident, they are far more likely to start therapy and remain adherent to treatment.
What Pharma Leaders Should Be Thinking About Now
As Bob and Jason explain in the episode, the evolution of the patient journey presents both a challenge and an opportunity.
Healthcare innovation is moving faster than ever before. New therapies are becoming more specialized and more powerful. But without clear education and support, patients may struggle to navigate the complexity that comes with these advances.
Pharma leaders must begin thinking differently about patient experience, patient services, and patient education. The organizations that succeed will be those that help patients move from confusion to clarity.
Helping patients understand their condition, trust their treatment plan, and feel supported throughout their journey will ultimately improve both outcomes and the overall healthcare experience.